Medindia LOGIN REGISTER
Medindia

Side effect(s) of Ibrutinib


Review the side-effects of Ibrutinib as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.

If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.

  General:
Fever, chills, infections

  Gastrointestinal:
Stomach pain, indigestion, decreased appetite, nausea, vomiting, diarrhea, constipation, mouth sores.

  Musculoskeletal system:
Muscle spasm, pain in the joints and bones.

  Blood:
Reduced platelet, white blood cell and red blood cell counts. Bleeding may occur resulting in bruising in the skin, bloody or black stools, dark brown, pink or red-colored urine, or dizziness, confusion, speech problems, headache or seizures.

  Respiratory system:
Cough, shortness of breath.

  Skin:
Itching of the skin, skin rashes and skin cancers. Other cancers may also occur.

  Central Nervous system:
Dizziness, headache.

  Cardiovascular system:
Discomfort in the chest, irregular or fast heartbeats, high blood pressure.

  Urinary system:
Decreased urination.

Other Precautions :

• Avoid eating Seville oranges or grapefruit and do not drink grapefruit juice while taking ibrutinib as it may increase the concentration of the drug in the blood.

Drug Name : Ibrutinib

Ibrutinib generic Ibrutinib belongs to a group of medications called as kinase inhibitors. It is prescribed for the treatment of cancer of the cells of the immune system (mantle cell lymphoma) in patients who have been treated earlier with a minimum of one chemotherapy medication. Ibrutinib is also used in the treatment of a cancer that begins in the white blood cells (chronic lymphocytic leukemia) and in the lymph nodes (small lymphocytic lymphoma), and a type of non-Hodgkin’s lymphoma (Waldenström macroglobulinemia). It mainly stops the spread of the cancer cells by blocking the abnormal proteins that signals them to multiply.


Advertisement